Michelle Antoine | |
---|---|
Nationality | Trinidadian |
Alma mater | Albert Einstein College of Medicine Spelman College |
Scientific career | |
Institutions | National Institute on Alcohol Abuse and Alcoholism |
Michelle Antoine is a Trinidadian neuroscientist. She is acting chief of the section on neural circuits in the National Institute on Alcohol Abuse and Alcoholism (NIAAA). [1] Her research has redefined the classical notion of excitatory-inhibitory balance and its role in autism. [2] She continues to study the synaptic and circuit pathways that contribute to nervous system disorders, autism spectrum disorder in particular. [3]
Michelle Antoine was born in Trinidad and Tobago, where she went to the all-female Bishop Anstey High School. [4] After graduation from high school, she attended Spelman College where she received a Bachelor’s of Science in Biology and Mathematics. Following her graduation from Spelman College, Antoine went on to attend graduate school at Albert Einstein College of Medicine. [4]
Antoine completed her postdoctoral training at the University of California, Berkeley, in Daniel Feldman’s laboratory, where she was a Miller Research Fellow and a UC President’s Postdoctoral Fellow. [5]
Antoine wrote her dissertation about a causative link between inner ear defects and long-term striatal dysfunction. [5] At Albert Einstein College of Medicine, Antoine noticed unusual hyper activity in mice. Antoine later found that inner ear dysfunction in mice has a direct causal relationship with neurological changes that increase hyperactivity. With these findings, Antoine provided two brain proteins as potential intervention targets for behavioral abnormalities. These proteins include pERK (phosphorylated extracellular signal-regulated kinase) and pCREB (phospho-cAMP response-element binding protein). [6]
As a Miller Postdoctoral Fellow, Antoine worked with Daniel Feldman's team to analyze four mouse models in relation to the 'signaling imbalance theory', which is a well known hypothesis about the origin of autism in the brain. This theory states that the brains of autistic people have an excess of excitatory brain activity, but not enough inhibitory signals to counterbalance. As a result, the neurons in brains of autistic people fire at a higher rate than normal, which leads to further motor disabilities, sensory issues, and additional autism traits. The team negated the original hypothesis of this theory, and instead proved that this imbalance is a compensatory effect, as opposed to the origin of autism. They found that the difference in the signals in the autism brains is of a type that stabilizes neurons’ firing rates rather than increasing them, which is suggestive of a compensatory response. [7] [8]
Antoine currently works at the NIAAA, where her lab studies normal brains versus diseased brains and brain circuit function from the lens of developmental disabilities such as autism spectrum disorder. [9]
Binaural fusion or binaural integration is a cognitive process that involves the combination of different auditory information presented binaurally, or to each ear. In humans, this process is essential in understanding speech in noisy and reverberent environments.
In neuroscience, homeostatic plasticity refers to the capacity of neurons to regulate their own excitability relative to network activity. The term homeostatic plasticity derives from two opposing concepts: 'homeostatic' and plasticity, thus homeostatic plasticity means "staying the same through change". In the nervous system, neurons must be able to evolve with the development of their constantly changing environment while simultaneously staying the same amidst this change. This stability is important for neurons to maintain their activity and functionality to prevent neurons from carcinogenesis. At the same time, neurons need to have flexibility to adapt to changes and make connections to cope with the ever-changing environment of a developing nervous system.
Neurexins (NRXN) are a family of presynaptic cell adhesion proteins that have roles in connecting neurons at the synapse. They are located mostly on the presynaptic membrane and contain a single transmembrane domain. The extracellular domain interacts with proteins in the synaptic cleft, most notably neuroligin, while the intracellular cytoplasmic portion interacts with proteins associated with exocytosis. Neurexin and neuroligin "shake hands," resulting in the connection between the two neurons and the production of a synapse. Neurexins mediate signaling across the synapse, and influence the properties of neural networks by synapse specificity. Neurexins were discovered as receptors for α-latrotoxin, a vertebrate-specific toxin in black widow spider venom that binds to presynaptic receptors and induces massive neurotransmitter release. In humans, alterations in genes encoding neurexins are implicated in autism and other cognitive diseases, such as Tourette syndrome and schizophrenia.
Neuroligin (NLGN), a type I membrane protein, is a cell adhesion protein on the postsynaptic membrane that mediates the formation and maintenance of synapses between neurons. Neuroligins act as ligands for β-neurexins, which are cell adhesion proteins located presynaptically. Neuroligin and β-neurexin "shake hands", resulting in the connection between two neurons and the production of a synapse. Neuroligins also affect the properties of neural networks by specifying synaptic functions, and they mediate signalling by recruiting and stabilizing key synaptic components. Neuroligins interact with other postsynaptic proteins to localize neurotransmitter receptors and channels in the postsynaptic density as the cell matures. Additionally, neuroligins are expressed in human peripheral tissues and have been found to play a role in angiogenesis. In humans, alterations in genes encoding neuroligins are implicated in autism and other cognitive disorders. Antibodies in a mother from previous male pregnancies against neuroligin 4 from the Y chromosome increase the probability of homosexuality in male offspring.
Teashirt homolog 3 is a protein that in humans is encoded by the TSHZ3 gene. In mice, it is a necessary part of the neural circuitry that controls breathing. The gene is also a homolog of the Drosophila melanogaster teashirt gene, which encodes a zinc finger transcription factor important for development of the trunk.
Michael Greenberg is an American neuroscientist who specializes in molecular neurobiology. He served as the Chair of the Department of Neurobiology at Harvard Medical School from 2008 to 2022.
Neurogenomics is the study of how the genome of an organism influences the development and function of its nervous system. This field intends to unite functional genomics and neurobiology in order to understand the nervous system as a whole from a genomic perspective.
The development of an animal model of autism is one approach researchers use to study potential causes of autism. Given the complexity of autism and its etiology, researchers often focus only on single features of autism when using animal models.
The mechanisms of autism are the molecular and cellular processes believed to cause or contribute to the symptoms of autism. Multiple processes are hypothesized to explain different autism spectrum features. These hypotheses include defects in synapse structure and function, reduced synaptic plasticity, disrupted neural circuit function, gut–brain axis dyshomeostasis, neuroinflammation, and altered brain structure or connectivity.
Mary Elizabeth Hatten is the Frederick P. Rose Professor of neuroscience at the Rockefeller University, where she became the first female full professor in 1992. She studies the manner in which neurons migrate in the brain, which has implications for many neurological diseases, as well as cancer. Her research led to her being elected to the National Academy of Sciences in 2017.
Nicola J. Allen is a British neuroscientist. Allen studies the role of astrocytes in brain development, homeostasis, and aging. Her work uncovered the critical roles these cells play in brain plasticity and disease. Allen is currently an associate professor at the Salk Institute for Biological Studies and Hearst Foundation Development Chair.
Nadine Gogolla is a Research Group Leader at the Max Planck Institute of Neurobiology in Martinsried, Germany as well as an Associate Faculty of the Graduate School for Systemic Neuroscience. Gogolla investigates the neural circuits underlying emotion to understand how the brain integrates external cues, feeling states, and emotions to make calculated behavioral decisions. Gogolla is known for her discovery using machine learning and two-photon microscopy to classify mouse facial expressions into emotion-like categories and correlate these facial expressions with neural activity in the insular cortex.
Camilla Bellone is an Italian neuroscientist and assistant professor in the Department of Basic Neuroscience at the University of Geneva, in Switzerland. Bellone's laboratory explores the molecular mechanisms and neural circuits underlying social behavior and probes how defects at the molecular and circuit level give rise to psychiatric disease states such as Autism Spectrum Disorders.
Lauren Orefice is an American neuroscientist and assistant professor in the Department of Molecular Biology at Massachusetts General Hospital and in the Department of Genetics at Harvard Medical School. Orefice has made innovative discoveries about the role of peripheral nerves and sensory hypersensitivity in the development of Autism-like behaviors. Her research now focuses on exploring the basic biology of somatosensory neural circuits for both touch and gastrointestinal function in order to shed light on how peripheral sensation impacts brain development and susceptibility to diseases like Autism Spectrum Disorders.
Michelle Gray is an American neuroscientist and assistant professor of neurology and neurobiology at the University of Alabama Birmingham. Gray is a researcher in the study of the biological basis of Huntington's disease (HD). In her postdoctoral work, she developed a transgenic mouse line, BACHD, that is now used worldwide in the study of HD. Gray's research now focuses on the role of glial cells in HD. In 2020 Gray was named one of the 100 Inspiring Black Scientists in America by Cell Press. She is also a member of the Hereditary Disease Foundation’s scientific board.
Willardiine (correctly spelled with two successive i's) or (S)-1-(2-amino-2-carboxyethyl)pyrimidine-2,4-dione is a chemical compound that occurs naturally in the seeds of Mariosousa willardiana and Acacia sensu lato. The seedlings of these plants contain enzymes capable of complex chemical substitutions that result in the formation of free amino acids (See:#Synthesis). Willardiine is frequently studied for its function in higher level plants. Additionally, many derivates of willardiine are researched for their potential in pharmaceutical development. Willardiine was first discovered in 1959 by R. Gmelin, when he isolated several free, non-protein amino acids from Acacia willardiana (another name for Mariosousa willardiana) when he was studying how these families of plants synthesize uracilyalanines. A related compound, Isowillardiine, was concurrently isolated by a different group, and it was discovered that the two compounds had different structural and functional properties. Subsequent research on willardiine has focused on the functional significance of different substitutions at the nitrogen group and the development of analogs of willardiine with different pharmacokinetic properties. In general, Willardiine is the one of the first compounds studied in which slight changes to molecular structure result in compounds with significantly different pharmacokinetic properties.
Mary Kay Lobo is an American psychiatric neuroscientist who is a Professor of Neurobiology at the University of Maryland School of Medicine. Her research considers the molecular mechanisms that underpin drug addiction and depression. She was named a finalist in the 2011 Blavatnik Awards for Young Scientists.
The pathophysiology of autism is the study of the physiological processes that cause or are otherwise associated with autism spectrum disorders.
Patrícia Monteiro is a Portuguese neuroscientist and Research Group Leader at the Faculty of Medicine of the University of Porto (FMUP). She is known for her research on the neural mechanisms underlying neuropsychiatric and neurodevelopmental disorders.
This article needs additional or more specific categories .(January 2022) |